Clinical Trial Update: Impact of Immunonutrition on the Patients With Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating immunonutrition in patients with cystic fibrosis and malnutrition. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Malnutrition
• Oxidative Stress

Snippet

Sponsor: University Hospital, Motol | Conditions: Cystic Fibrosis, Malnutrition | Phase 4 | Status: UNKNOWN